A “Catastrophic” Heparin-Induced Thrombocytopenia

Background. Heparin-induced thrombocytopenia (HIT) is a transient, antibody-mediated thrombocytopenia syndrome that usually follows exposure to unfractioned heparin (UFH) or low-molecular-weight heparin (LMWH). In contrast to other pathological conditions which lead to thrombocytopenia and bleeding...

Full description

Saved in:
Bibliographic Details
Main Authors: D. Barcellona, M. Melis, G. Floris, A. Mameli, A. Muroni, G. Defazio, F. Marongiu
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2020/6985020
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566540564692992
author D. Barcellona
M. Melis
G. Floris
A. Mameli
A. Muroni
G. Defazio
F. Marongiu
author_facet D. Barcellona
M. Melis
G. Floris
A. Mameli
A. Muroni
G. Defazio
F. Marongiu
author_sort D. Barcellona
collection DOAJ
description Background. Heparin-induced thrombocytopenia (HIT) is a transient, antibody-mediated thrombocytopenia syndrome that usually follows exposure to unfractioned heparin (UFH) or low-molecular-weight heparin (LMWH). In contrast to other pathological conditions which lead to thrombocytopenia and bleeding complications, HIT results in a paradoxical prothrombotic state. It is caused by antibodies directed to complexes containing UFH or LMWH and a self-platelet protein: the platelet factor 4 (PF4). The heparin-PF4 immune complex leads to activation of platelets, monocytes, and endothelial cells which release procoagulant proteins and tissue factor with subsequent blood coagulation activation. Case Report. We describe the case of a woman undergone to knee replacement and affected by urosepsis who developed a HIT after exposure to enoxaparin. The thrombotic burden was very impressive involving the arterial and venous cerebral vessel and the venous pulmonary, hepatic, and inferior legs vascular beds. The patient was successfully treated with fondaparinux without recurrent thrombosis or bleeding. The clinical scenario could be named “catastrophic HIT” like the catastrophic antiphospholipid syndrome since they have a similar pathogenetic mechanism involving both platelets and monocytes procoagulant activities and a similar clinical manifestation with a life-threatening multiple arterial and/or venous thromboses. Conclusion. Patients presenting with HIT could show a very impressive thrombotic burden resembling to that of the catastrophic antiphospholipid syndrome. A careful differential diagnosis should be made towards other pathological conditions which lead to thrombocytopenia to avoid an unnecessary and potentially harmful platelet transfusion. Although fondaparinux is off-label, its use in patients with HIT is simple and seems to be effective.
format Article
id doaj-art-5f733ce1b52644c0b9aa3c6339554998
institution Kabale University
issn 1687-9627
1687-9635
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-5f733ce1b52644c0b9aa3c63395549982025-02-03T01:03:48ZengWileyCase Reports in Medicine1687-96271687-96352020-01-01202010.1155/2020/69850206985020A “Catastrophic” Heparin-Induced ThrombocytopeniaD. Barcellona0M. Melis1G. Floris2A. Mameli3A. Muroni4G. Defazio5F. Marongiu6Haemostasis and Thrombosis Departmental Unit, AOU Cagliari, Department of Medical Science and Public Health, University of Cagliari, Cagliari, ItalyNeurology Complex Unit, AOU Cagliari, Department of Medical Science and Public Health, University of Cagliari, Cagliari, ItalyNeurology Complex Unit, AOU Cagliari, Department of Medical Science and Public Health, University of Cagliari, Cagliari, ItalyHaemostasis and Thrombosis Departmental Unit, AOU Cagliari, Department of Medical Science and Public Health, University of Cagliari, Cagliari, ItalyNeurology Complex Unit, AOU Cagliari, Department of Medical Science and Public Health, University of Cagliari, Cagliari, ItalyNeurology Complex Unit, AOU Cagliari, Department of Medical Science and Public Health, University of Cagliari, Cagliari, ItalyInternal Medicine Complex Unit, AOU Cagliari, Department of Medical Science and Public Health, University of Cagliari, Cagliari, ItalyBackground. Heparin-induced thrombocytopenia (HIT) is a transient, antibody-mediated thrombocytopenia syndrome that usually follows exposure to unfractioned heparin (UFH) or low-molecular-weight heparin (LMWH). In contrast to other pathological conditions which lead to thrombocytopenia and bleeding complications, HIT results in a paradoxical prothrombotic state. It is caused by antibodies directed to complexes containing UFH or LMWH and a self-platelet protein: the platelet factor 4 (PF4). The heparin-PF4 immune complex leads to activation of platelets, monocytes, and endothelial cells which release procoagulant proteins and tissue factor with subsequent blood coagulation activation. Case Report. We describe the case of a woman undergone to knee replacement and affected by urosepsis who developed a HIT after exposure to enoxaparin. The thrombotic burden was very impressive involving the arterial and venous cerebral vessel and the venous pulmonary, hepatic, and inferior legs vascular beds. The patient was successfully treated with fondaparinux without recurrent thrombosis or bleeding. The clinical scenario could be named “catastrophic HIT” like the catastrophic antiphospholipid syndrome since they have a similar pathogenetic mechanism involving both platelets and monocytes procoagulant activities and a similar clinical manifestation with a life-threatening multiple arterial and/or venous thromboses. Conclusion. Patients presenting with HIT could show a very impressive thrombotic burden resembling to that of the catastrophic antiphospholipid syndrome. A careful differential diagnosis should be made towards other pathological conditions which lead to thrombocytopenia to avoid an unnecessary and potentially harmful platelet transfusion. Although fondaparinux is off-label, its use in patients with HIT is simple and seems to be effective.http://dx.doi.org/10.1155/2020/6985020
spellingShingle D. Barcellona
M. Melis
G. Floris
A. Mameli
A. Muroni
G. Defazio
F. Marongiu
A “Catastrophic” Heparin-Induced Thrombocytopenia
Case Reports in Medicine
title A “Catastrophic” Heparin-Induced Thrombocytopenia
title_full A “Catastrophic” Heparin-Induced Thrombocytopenia
title_fullStr A “Catastrophic” Heparin-Induced Thrombocytopenia
title_full_unstemmed A “Catastrophic” Heparin-Induced Thrombocytopenia
title_short A “Catastrophic” Heparin-Induced Thrombocytopenia
title_sort catastrophic heparin induced thrombocytopenia
url http://dx.doi.org/10.1155/2020/6985020
work_keys_str_mv AT dbarcellona acatastrophicheparininducedthrombocytopenia
AT mmelis acatastrophicheparininducedthrombocytopenia
AT gfloris acatastrophicheparininducedthrombocytopenia
AT amameli acatastrophicheparininducedthrombocytopenia
AT amuroni acatastrophicheparininducedthrombocytopenia
AT gdefazio acatastrophicheparininducedthrombocytopenia
AT fmarongiu acatastrophicheparininducedthrombocytopenia
AT dbarcellona catastrophicheparininducedthrombocytopenia
AT mmelis catastrophicheparininducedthrombocytopenia
AT gfloris catastrophicheparininducedthrombocytopenia
AT amameli catastrophicheparininducedthrombocytopenia
AT amuroni catastrophicheparininducedthrombocytopenia
AT gdefazio catastrophicheparininducedthrombocytopenia
AT fmarongiu catastrophicheparininducedthrombocytopenia